These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3226307)

  • 21. [Chemotaxis of granular leukocytes and its biochemical, morphological structure].
    Hirashima M; Hirotsu H; Hayashi H
    Nihon Rinsho; 1981 Aug; 39(8):2701-8. PubMed ID: 7038196
    [No Abstract]   [Full Text] [Related]  

  • 22. Specific modulation of the intracellular pH of rabbit neutrophils by chemotactic factors.
    Molski TF; Naccache PH; Volpi M; Wolpert LM; Sha'afi RI
    Biochem Biophys Res Commun; 1980 May; 94(2):508-14. PubMed ID: 7396914
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of neutrophil shape change by an inhibitor of chemotaxis.
    Donabedian H; Sawyer T; Senitzer D
    J Leukoc Biol; 1987 Nov; 42(5):510-8. PubMed ID: 3479513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation assays for proteins of the two-component regulatory system controlling chemotaxis in Escherichia coli.
    Hess JF; Bourret RB; Simon MI
    Methods Enzymol; 1991; 200():188-204. PubMed ID: 1956317
    [No Abstract]   [Full Text] [Related]  

  • 25. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological studies with human leukocyte inhibitory factor.
    Borish L; Rocklin R
    Immunol Ser; 1992; 57():373-85. PubMed ID: 1504141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis.
    Dudez TS; Chanson M; Schlegel-Haueter SE; Suter S
    J Infect Dis; 2002 Sep; 186(6):774-81. PubMed ID: 12198611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte locomotion and chemotaxis: effects of bacteria and viruses.
    Wilkinson PC
    Rev Infect Dis; 1980; 2(2):293-318. PubMed ID: 6994210
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors.
    Yamaki T; Uede T; Shijubo N; Kikuchi K
    J Immunol; 1988 Jun; 140(12):4388-96. PubMed ID: 3286773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of a neutrophil chemotactic factor from Dirofilaria immitis.
    Horii Y; Fujita K; Owhashi M
    J Parasitol; 1986 Apr; 72(2):315-20. PubMed ID: 3525795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of carboxypeptidase N by affinity chromatography].
    Simonianová E; Petáková M
    Cesk Farm; 1978 Mar; 27(2):74-6. PubMed ID: 667975
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of hirudin on the chemotactic properties of alpha-thrombin.
    Morin A; Marchand-Arvier M; Doutremepuich C; Vigneron C
    Haemostasis; 1991; 21 Suppl 1():32-5. PubMed ID: 1894195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of a new arginine carboxypeptidase in human serum.
    Hendriks D; Wang W; Scharpé S; Lommaert MP; van Sande M
    Biochim Biophys Acta; 1990 Apr; 1034(1):86-92. PubMed ID: 2328266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemotaxis system.
    Ward PA
    Monogr Pathol; 1982; (23):54-61. PubMed ID: 7121474
    [No Abstract]   [Full Text] [Related]  

  • 37. A chemotactic inhibitor in synovial fluid.
    Matzner Y; Partridge RE; Babior BM
    Immunology; 1983 May; 49(1):131-8. PubMed ID: 6840801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large scale purification of C1-inactivator (C1-INA), carboxypeptidase N (Cp N) and kallikrein (KK).
    Steinbuch M; Granier C; Pejaudier L; Kichenin V
    Adv Exp Med Biol; 1983; 156():193-200. PubMed ID: 6344569
    [No Abstract]   [Full Text] [Related]  

  • 39. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiological studies with human leukocyte inhibitory factor.
    Borish LC; Rocklin RE
    Surv Immunol Res; 1985; 4(3):230-7. PubMed ID: 3003858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.